The European Medicines Agency, which is leaving the UK because of Brexit, has resumed its battle — at the last minute — to avoid paying a £500m rent bill for its London headquarters.
The legal dispute with Canary Wharf Group, its landlord, has been watched closely as it could set a precedent for any UK-based business to argue that Britain’s departure from the European Union should allow it to set aside contracts.
In February a High Court judge dismissed the agency’s claims that its 25-year lease of offices in Canary Wharf would be legally “frustrated” as a result of Brexit. However, the agency lodged an eleventh-hour appeal against the judgment on Monday, the deadline.
